Lung Hyperlucency: A Clinical-Radiologic Algorithmic Approach to Diagnosis.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
01 2020
Historique:
received: 04 02 2019
revised: 27 05 2019
accepted: 10 06 2019
pubmed: 30 7 2019
medline: 22 7 2020
entrez: 30 7 2019
Statut: ppublish

Résumé

Areas of diminished lung density are frequently identified both on routine chest radiographs and chest CT examinations. Colloquially referred to as hyperlucent foci of lung, a broad range of underlying pathophysiologic mechanisms and differential diagnoses account for these changes. Despite this, the spectrum of etiologies can be categorized into underlying parenchymal, airway, and vascular-related entities. The purpose of this review is to provide a practical diagnostic algorithmic approach to pulmonary hyperlucencies incorporating clinical history and characteristic imaging patterns to narrow the differential.

Identifiants

pubmed: 31356811
pii: S0012-3692(19)31381-9
doi: 10.1016/j.chest.2019.06.037
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-141

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Sujith V Cherian (SV)

Division of Pulmonary, Critical Care, and Sleep Medicine, University of Texas Health - McGovern Medical School, Houston, TX.

Francis Girvin (F)

Department of Radiology, Division of Thoracic Radiology, NYU Langone Health, New York, NY.

David P Naidich (DP)

Department of Radiology, Division of Thoracic Radiology, NYU Langone Health, New York, NY.

Stephen Machnicki (S)

Department of Radiology, Lenox Hill Hospital, New York, NY.

Kevin K Brown (KK)

Department of Medicine, National Jewish Health, Denver, CO.

Jay H Ryu (JH)

Mayo Clinic College of Medicine and Science, Rochester, MN.

Nishant Gupta (N)

Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, Cincinnati, OH.

Vishisht Mehta (V)

Division of Pulmonary Medicine, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Rosa M Estrada-Y-Martin (RM)

Division of Pulmonary, Critical Care, and Sleep Medicine, University of Texas Health - McGovern Medical School, Houston, TX.

Mangala Narasimhan (M)

Division of Pulmonary, Critical Care and Sleep Medicine, Long Island Jewish Medical Center, New Hyde Park, NY.

Margarita Oks (M)

Medicine and Radiology, Barbara and Donald Zuckerberg School of Medicine at Hofstra/Northwell, New York, NY.

Suhail Raoof (S)

Pulmonary, Critical Care & Sleep Medicine, Lenox Hill Hospital, New York, NY; Medicine and Radiology, Barbara and Donald Zuckerberg School of Medicine at Hofstra/Northwell, New York, NY. Electronic address: suhailraoof@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH